2023 annual financial data
Aptevo Therapeutics 2023 Operating margin
Aptevo Therapeutics 2023 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -28,878,000 USD and net income was -17,411,000 USD.
Operating cash flow was -11,730,000 USD.
Get free Aptevo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -28,878,000 USD
- Net income
- -17,411,000 USD
- Operating cash flow
- -11,730,000 USD